AI is already shaping how life sciences organizations run quality operations. The question isn’t whether to adopt it — it’s how to do so responsibly, defensibly, and in a way regulators will recognize.  This session covers where AI is delivering real value in QA today, what the FDA is signaling through recent guidance and its own internal AI use, and how to build a program that holds up under inspection.